Global Clinical Chemistry Analyzer Market Size study & Forecast, by Product (Analyzers, Reagents, Others), by Types of Test (Liver Panels, Electrolyte Panels, Thyroid Function Panels, Lipid Profiles, Others), by End User (Hospital, Diagnostic Laboratories

Global Clinical Chemistry Analyzer Market Size study & Forecast, by Product (Analyzers, Reagents, Others), by Types of Test (Liver Panels, Electrolyte Panels, Thyroid Function Panels, Lipid Profiles, Others), by End User (Hospital, Diagnostic Laboratories, Academic Institutes, Others) and Regional Analysis, 2023-2030

Global Clinical Chemistry Analyzer Market is valued at approximately USD 13.15 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.28% over the forecast period 2023-2030. A Clinical Chemistry Analyzer is a medical laboratory instrument used to analyze various chemical components in biological samples such as blood, serum, plasma, urine, and other bodily fluids. This type of analyzer is an essential tool in clinical chemistry, which is a branch of clinical pathology focused on studying the chemical composition of bodily fluids to aid in the diagnosis, treatment, and monitoring of diseases. The Clinical Chemistry Analyzer market is expanding because of factors such as rising geriatric population and increasing prevalence of chronic diseases.

The clinical chemistry analyzers conduct assays on samples such as blood, plasma, urine, and cerebrospinal fluid to find the presence of analytes linked to disease or medications. The global population is aging, particularly in developed countries. With aging, there is a higher susceptibility to chronic illnesses and a greater need for diagnostic tools such as clinical chemistry analyzers to monitor and manage these conditions effectively. According to a WHO document on ageing and health that was released in October 2021, around 1 in 6 people would be older than 60 by the year 2030. The same study predicts that 1.4 billion people, up from 1 billion in 2020, would be beyond the age of 60 by 2030. In addition, Clinical chemistry analyzers play a critical role in the evaluation of such chronic disorders by analyzing the lipids, electrolytes, plasma glucose levels, and other profiles of several components including blood, serum, plasma, and cerebrospinal fluid, among others. In turn, it is projected that the prevalence of chronic illnesses would increase, resulting in market growth. The GLOBOCAN 2020 report estimates that there were roughly 19,292,789 new cases of cancer worldwide in 2020. By 2040, there would likely be 28,887,940 instances, according to projections. Additionally, according to the IDF Diabetes Atlas Tenth Edition 2021, about 537 million adults worldwide were discovered to have diabetes in 2021, with estimates showing that figure wouldrise to 643 million by 2030 and 783 million by 2045. In addition, growing demand for point-of-care testing and rising technological advancements in clinical chemistry analyzers are some factors creating lucrative opportunities for the market. However, the high cost of clinical chemistry analyzers, the lack of trained and qualified professional’s stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Chemistry Analyzer Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to factors such as rising disease prevalence, presence of key market players, increasing healthcare expenditure, rising investment for clinical development, and rising favorable government initiatives in the region. Whereas, Asia Pacific is projected to register significant growth owing to factors such as a rising geriatric population, rising prevalence of chronic diseases, and rising healthcare investments in the region.

Major market player included in this report are:
Abbott Laboratories
Danaher Corporation (Beckman Coulter, Inc.)
Elitech Group
F. Hoffmann-La Roche AG
Horiba, Ltd.
Johnson & Johnson Pvt Ltd
Mindray Medical International Limited
Siemens Healthcare Private Limited
Sysmex Corporation
Thermo Fisher Scientific Inc.

Recent Developments in the Market:
In May 2022, Mindray unveiled the BS-600M, a powerful, efficient chemistry analyzer, to increase productivity, efficiency, and dependability in medium-volume laboratories.
In April 2022, Sysmex Europe unveiled the XQ-320 XQ-Series Automated Haematology Analyzer as a brand-new three-part differential system. The XQ-320 uses trustworthy technology and a new level of use to give outstanding quality in a range of clinical laboratory applications.

Global Clinical Chemistry Analyzer Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Types of Test, End user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Analyzers
Reagents
Others

By Types of Type:
Liver Panels
Electrolyte Panels
Thyroid Function Panels
Lipid Profiles
Others

By End User:
Hospital
Diagnostic Laboratories
Academic Institutes
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Abbott Laboratories
Danaher Corporation (Beckman Coulter, Inc.)
Elitech Group
F. Hoffmann-La Roche AG
Horiba, Ltd.
Johnson & Johnson Pvt Ltd
Mindray Medical International Limited
Siemens Healthcare Private Limited
Sysmex Corporation
Thermo Fisher Scientific Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.